Healthcare provider profile · identity verified

Daniel Amoah, MD

Family Practice · BRADENTON, FL · NPI 1063612927

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	804	238
Atorvastatin Calcium	Atorvastatin Calcium	522	159
Levothyroxine Sodium	Levothyroxine Sodium	479	116
Amlodipine Besylate	Amlodipine Besylate	425	113
Losartan Potassium	Losartan Potassium	318	90
Lisinopril	Lisinopril	284	81
Omeprazole	Omeprazole	262	76
Duloxetine Hcl	Duloxetine Hcl	250	76
Albuterol Sulfate Hfa	Albuterol Sulfate	237	74
Metformin Hcl	Metformin Hcl	213	56
Pantoprazole Sodium	Pantoprazole Sodium	194	61
Alprazolam	Alprazolam	191	36
Metoprolol Succinate	Metoprolol Succinate	184	55
Tamsulosin Hcl	Tamsulosin Hcl	174	56
Gabapentin	Gabapentin	153	50
Simvastatin	Simvastatin	143	36
Furosemide	Furosemide	140	49
Bupropion Xl	Bupropion Hcl	136	44
Metoprolol Tartrate	Metoprolol Tartrate	134	42
Hydrochlorothiazide	Hydrochlorothiazide	130	35
Trazodone Hcl	Trazodone Hcl	117	32
Metformin Hcl Er	Metformin Hcl	115	36
Allopurinol	Allopurinol	114	30
Buspirone Hcl	Buspirone Hcl	113	28
Celecoxib	Celecoxib	107	38
Fluoxetine Hcl	Fluoxetine Hcl	104	38
Sertraline Hcl	Sertraline Hcl	104	28
Potassium Chloride	Potassium Chloride	103	30
Clopidogrel	Clopidogrel Bisulfate	102	31
Azithromycin	Azithromycin	100	85
Alendronate Sodium	Alendronate Sodium	96	27
Prednisone	Prednisone	95	73
Temazepam	Temazepam	95	15
Tramadol Hcl	Tramadol Hcl	94	29
Jardiance	Empagliflozin	91	22
Eliquis	Apixaban	88	25
Fluticasone Propionate	Fluticasone Propionate	85	28
Telmisartan	Telmisartan	79	26
Escitalopram Oxalate	Escitalopram Oxalate	78	19
Baclofen	Baclofen	74	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	21
Methylprednisolone	Methylprednisolone	73	66
Montelukast Sodium	Montelukast Sodium	73	20
Atenolol	Atenolol	72	17
Doxycycline Hyclate	Doxycycline Hyclate	71	52
Glimepiride	Glimepiride	71	21
Zolpidem Tartrate	Zolpidem Tartrate	71	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	69	15
Carvedilol	Carvedilol	68	21
Famotidine	Famotidine	65	21
Acetaminophen-Codeine	Acetaminophen With Codeine	63	23
Paroxetine Hcl	Paroxetine Hcl	60	13
Clonazepam	Clonazepam	57	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	13
Clonidine Hcl	Clonidine Hcl	51	18
Synthroid	Levothyroxine Sodium	51	suppressed
Ozempic	Semaglutide	49	11
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Lorazepam	Lorazepam	48	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	39
Ciprofloxacin Hcl	Ciprofloxacin Hcl	47	33
Ketoconazole	Ketoconazole	47	22
Spironolactone	Spironolactone	47	17
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	46	15
Sumatriptan Succinate	Sumatriptan Succinate	46	suppressed
Ondansetron Odt	Ondansetron	45	15
Mirtazapine	Mirtazapine	44	17
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Glipizide	Glipizide	42	14
Hydralazine Hcl	Hydralazine Hcl	41	12
Finasteride	Finasteride	40	11
Colchicine	Colchicine	39	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	11
Meloxicam	Meloxicam	37	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	30
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	21
Valacyclovir	Valacyclovir Hcl	34	17
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Topiramate	Topiramate	32	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Fluconazole	Fluconazole	30	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	28	suppressed
Valsartan	Valsartan	28	suppressed
Cephalexin	Cephalexin	27	14
Ezetimibe	Ezetimibe	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Ramipril	Ramipril	26	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Digoxin	Digoxin	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Nitroglycerin	Nitroglycerin	20	12
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Risperidone	Risperidone	18	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Glipizide Er	Glipizide	14	suppressed
Zonisamide	Zonisamide	14	suppressed
Amoxicillin	Amoxicillin	13	11
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Valproic Acid	Valproic Acid	13	suppressed
Acamprosate Calcium	Acamprosate Calcium	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	12	suppressed
Estradiol	Estradiol	12	suppressed
Lactulose	Lactulose	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Levofloxacin	Levofloxacin	12	11
Nystatin	Nystatin	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Diazepam	Diazepam	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error